You are here

Updates on Doravirine, Investigational New Drugs

Tuesday, October 16, 2018

TargetHIV

AIDSinfo has published a number of new and updated drug fact sheets. Among these are several on the recently-approved NNRTI Doravirine (Pifeltro), which will be marketed as Delstrigo as part of a combination antiretroviral regimen. The AETC NCRC ShareSpot has also prepared a summary, Doravirine--New NNRTI Approved by FDA, by Susa Coffey, MD.

In addition to the Doravirine fact sheets, see other See AIDSinfo updates on New Investigational and Recently Updated Drug Fact Sheets

Total views: 221